Ticagrelor versus clopidogrel for recovery of vascular function immediately after successful chronic coronary total occlusion recanalization: A randomized clinical trial

Coronary vascular function of a chronic coronary total occlusion (CTO) immediately after recanalization is known to be poor. We sought if ticagrelor may augment adenosine-induced coronary blood flow vs. clopidogrel immediately after successful CTO percutaneous coronary intervention (PCI).

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2018-10, Vol.204, p.205-209
Hauptverfasser:	Brugaletta, Salvatore, Gomez-Lara, Josep, Caballero, Juan, Ortega-Paz, Luis, Teruel, Luis, Fernandez, Miriam Jimenez, Romaguera, Rafael, Martinez, Vicente Alcalde, Ñato, Marcos, Navarro, Eduardo Molina, Gomez-Hospital, Joan-Antoni, Vilches, Concepcion Correa, Joyera, Maria, Cequier, Angel, Angiolillo, Dominick J, Sabate, Manel
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine Age Blood flow Clinical trials Clopidogrel Clopidogrel - therapeutic use Coronary Circulation - drug effects Coronary Occlusion - drug therapy Coronary Occlusion - surgery Humans Ischemia Nitrates Occlusion Patients Percutaneous Coronary Intervention Platelet Aggregation Inhibitors - therapeutic use Prospective Studies Purinergic P2Y Receptor Antagonists - therapeutic use Recovery (Medical) Ticagrelor - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Coronary vascular function of a chronic coronary total occlusion (CTO) immediately after recanalization is known to be poor. We sought if ticagrelor may augment adenosine-induced coronary blood flow vs. clopidogrel immediately after successful CTO percutaneous coronary intervention (PCI).
ISSN:	0002-8703 1097-6744
DOI:	10.1016/j.ahj.2018.07.013